Gelteq Ltd
GELS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001920092
No open-market purchases or sales by Gelteq Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $73.3K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Gelteq Ltd changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 5 | 6 | +1 |
| Shares | 62.4K | 110.0K | +47.6K (+76.3%) |
| Value | $40.9K | $73.3K | +$32.4K (+79.3%) |
New holders (3)
Institutions that held Gelteq Ltd at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 33,238 | $22.3K | 0.00% |
| Jane Street Group, LLC | 30,161 | $20.2K | 0.00% |
| Morgan Stanley | 15,000 | $10.1K | 0.00% |
Sold out (2)
Institutions that held Gelteq Ltd at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Private Advisor Group, LLC | 16,668 | $11.0K |
| Two Sigma Investments, LP | 10,052 | $6.64K |